转录因子Maf促进抑制剂Zeb2的表达,以驱动原始血液形成中的微质发育
Jing Chen1, Siling Du2, Wenxuan Cheng3
1Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA; Medical Scientist Training Program, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Immunity
|December 27, 2025
概括
微细胞和巨细胞通过不同的遗传途径发展. 转录因子Maf和Jun控制原始血液形成,驱动巨细胞的发展,独立于Zeb2增强剂.
科学领域:
- 免疫学 免疫学 免疫学
- 发展生物学 发展生物学
- 血液形成 血液形成 血液形成
背景情况:
- 微质起源于原始的造血,与其他来自最终的造血的组织居民巨细胞不同.
- 巨细胞的发育通常需要指E-box-binding homeobox 2 (Zeb2) 基因,最终的造血依赖于特定的Zeb2增强剂.
- 在缺乏这种特定的Zeb2增强剂的小鼠中,微细胞的发育不受影响,这表明有一个独特的遗传程序.
研究的目的:
- 阐明在原始血液形成过程中控制巨细胞发育的独特分子机制.
- 确定早期发育中负责Zeb2-独立巨细胞发育的遗传因素.
主要方法:
- 在野生型和Zeb2增强剂缺乏的小鼠中对巨细胞发育的比较分析.
- 识别和表征涉及原始造血原始体的转录因子.
- 功能性测试,以评估已识别的转录因子在Zeb2表达和巨分化中的作用.
主要成果:
- 缺少Zeb2增强剂的小鼠中的所有巨细胞都源自原始血液形成.
- 转录因子musculoaponeurotic fibrosarcoma瘤基因同源 (Maf) 和Jun在原始的造血祖先中被确定,但不是在后来的波浪中.
- Maf和Jun合作诱导了Zeb2表达,绕过了对-165kb增强剂的需求,并恢复了缺陷小鼠的大菌发育.
- 马夫缺乏导致原始微细胞发育的严重减少.
结论:
- 独特的转录途径控制了原始和最终血液形成期间的巨细胞发育.
- Maf和Jun是原始血液形成衍生的巨细胞发育的关键调节者,独立于正规的Zeb2增强剂运作.
- 这些发现揭示了对微质和其他原始巨细胞早期血统特征的新见解.
相关概念视频
02:23Master Transcription Regulators
7.6K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
01:30General Transcription Factors
6.6K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.6K
02:36RNA Polymerase II Accessory Proteins
10.7K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
10.7K
02:16Transcription Factors
82.1K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.1K
02:04Co-activators and Co-repressors
8.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.3K
01:29Somatic to iPS Cell Reprogramming
2.5K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.5K